First Page | Document Content | |
---|---|---|
Date: 2016-04-20 16:56:32Chemistry Morphinans Neurochemistry Drug rehabilitation Opioid antagonists Organic chemistry Alcohols Euphoriants Buprenorphine Opioid use disorder Methadone Food and Drug Administration | Sunil Bhonsle Mar 2016 Corporate PresentationAdd to Reading ListSource URL: c.eqcdn.comDownload Document from Source WebsiteFile Size: 3,33 MBShare Document on Facebook |
Microsoft Word - VLD Packet.FINALDocID: 1rubZ - View Document | |
Atlantic Pharmaceuticals Announces Successful Pre-IND Meeting with the FDA on Immediate Release, Abuse-Deterrent Hydrocodone Atlanta, GA., August 13, 2013. Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical compaDocID: 1rtjz - View Document | |
TITAN PHARMACEUTICALS CORPORATE PRESENTATION SUNIL BHONSLE JUNE 2016 © 2016 TITAN PHARMACEUTICALS INC. NASDAQ:TTNPDocID: 1rsmr - View Document | |
Sunil Bhonsle Mar 2015 Corporate PresentationDocID: 1rrwl - View Document | |
Adapt v13_doc revisedDocID: 1rrqr - View Document |